In the estrogen-primed ovariectomized female rat, the administration of progesterone facilitates sexual receptivity and activates proceptivity for many hours. If the progesterone dose is large (e.g., 2.5 mg), a refractory period follows, during which time animals are less sensitive to additional progesterone.
Abstract
In the estrogen-primed ovariectomized female rat, the administration of progesterone facilitates sexual receptivity and activates proceptivity for many hours. If the progesterone dose is large (e.g., 2.5 mg), a refractory period follows, during which time animals are less sensitive to additional progesterone.
This refractory period has been termed "sequential inhibition" and has been correlated previously with decreased levels of cytosol progestin receptors in the mediobasal hypothalamuspreoptic area (MBH-POA).
Our present results indicate that the "sequential inhibition" of mating behavior by progesterone appears to involve a protein synthetic step that is not related causally to decreased levels of cytosol progestin receptors in the MBH-POA. Animals which received subcutaneous injections of the protein synthesis inhibitor, anisomycin (100 mg/kg in saline), 15 min prior to and again 3 hr after progesterone (2.5 mg in propylene glycol) treatment, displayed greater sexual receptivity at 24 hr than did animals which received subcutaneous saline injections. However, cytosol progestin receptor levels in the MBH-POA of animals which received anisomycin plus progesterone were decreased at 24 hr, relative to animals which received saline plus progesterone.
Anisomycin did not produce positive or negative behavioral effects at 24 hr when administered 15 min prior to and again 3 hr after propylene glycol, suggesting that the behavioral effects of anisomycin appear to be related to selective blockade of progesterone action. In separate experiments, we administered single subcutaneous injections of anisomycin at various times relative to progesterone (2.5 mg) treatment. According to the time course of effective anisomycin application, the presumed protein synthesis which is responsible for the inhibition of mating behavior occurs between 3 and 13 hr after the administration of progesterone.
During the rat estrous cycle, a 36-to 48-hr rise in plasma estradiol levels precedes a peak of plasma progesterone (Smith et al., 1975) . Progesterone rapidly activates sexual proceptivity (Beach, 1976) , such as hopdarting and ear wiggling, and rapidly facilitates sexual receptivity as measured by the lordosis quotient and lordosis quality score (Ball, 1937; Hardy, 1972; KubliGartias and Whalen, 1977 and receptivity on the day of estrus of the rat reproductive cycle (Morin, 1977) .
In the estrogen-primed ovariectomized female rat, the administration of progesterone activates proceptivity and facilitates receptivity for many hours (Meyerson, 1972; Hardy and DeBold, 1971; Boling and Blandau, 1937) . If the progesterone (P) dose is large (e.g., 2.5 mg), a refractory period ensues, during which time animals are behaviorally less sensitive to additional P (Zucker, 1966; Powers and Moreines, 1976; Blaustein and Wade, 1977; Blaustein and Feder, 1979) . This refractory period has been termed "sequential inhibition" (P owers and Moreines, 1976) . This period of decreased behavioral sensitivity to P has been correlated previously with decreased levels of cytosol progestin receptors in those areas of the brain known to mediate feminine sexual behavior, the mediobasal hypothalamus-preoptic area (MBH-POA), in both Vol. 1, No. 5, May 1981 guinea pig (Blaustein and Feder, 1979) and rat (Moguilewsky and Raynaud, 1979; Schwartz et al., 1979; Parsons et al., 1981a) . We now report that "sequential inhibition" of mating behavior by progesterone appears to involve a protein synthetic step that is not related causally to decreased cytosol progestin receptor levels in the MBH-POA. A large portion of the protein synthesis which appears to be essential for the inhibition of mating behavior occurs between 3 and 13 hr after the administration of progesterone.
Materials and Methods
The experimental design for our investigations is summarized in Figure 1 . Sexually inexperienced SpragueDawley female rats (200 to 225 gm) and sexually vigorous Long Evans male rats (250 to 300 gm) were obtained from Charles River Laboratories and were housed in temperature-controlled rooms with reversed day-night lighting (for details, see Parsons et al., 1980) . Females ovariectomized for 5 to 8 days received a 5-mm Silastic capsule containing crystalline 17P-estradiol, diluted 1:9 with cholesterol, at -72 hr. These capsules have been shown to produce estradiol levels in serum which are comparable to those seen in intact animals on proestrus (McGinnis et al., 1981) . All females received subcutaneous injections of P (2.5 mg in propylene glycol) or of propylene glycol (PG) at 0 hr. Females also received subcutaneous injections of the protein synthesis inhibitor, anisomycin (Pfizer Diagnostics), dissolved 20 mg/ml in saline or of saline (Rainbow et al., 1980) . Anisomycin or saline was administered 15 min prior to, and again 3 hr after, P or PG treatment. Twenty-four hours after P or PG treatment, some animals were sacrificed for cytosol progestin receptor measurements. All of the remaining animals received a subcutaneous injection of progesterone (0.5 mg) and were given mating tests 4 hr later (28 hr). Each female was allowed 10 mounts by an experienced male rat.
The lordosis quotient (LQ) was calculated as: No. lordoses/No. mounts x 100. The lordosis quality (LS) was measured as defined by Hardy and DeBold (1971) : 0, 1, 2, 3-representing no lordosis, light, moderate, and full dorsoflexion, respectively. The LS was computed as: CLS/lO. All behavioral results are means f SEM. Cytosol progestin receptor levels in MBH-POA and pituitary were quantified using the synthetic progestin, 3H-R5020, as the radioligand for an in vitro assay as described by MacLusky and McEwen (1978, 1980) . Briefly, aliquots (400 ~1) of cytosol were incubated with 200 ~1 of TEGD buffer (10 mM Tris, 1.5 mM disodium EDTA, 10% (v/v) glycerol adjusted to pH 7.4 with hydrochloric acid, 1 mM dithiothreitol added on day of use) for 4 to 6 hr at 4°C in the presence of 0.4 x lo-' M "H-R5020 (New England Nuclear). This concentration of 3H-R5020 has been shown to bind specifically progestin receptors and not other macromolecules, such as serum proteins (Blaustein and Feder, 1979; MacLusky and McEwen, 1980) . Corrections for nonspecific binding were made using parallel incubations containing 2 X lOpa M unlabeled R5020 in addition to 0.4 x lo-' M 3H-R5020. Bound 3H-R5020 was measured by gel filtration on Sephadex LH-20 (Pharmacia). Protein in the incubates was determined according to Bradford (1976) . Cytosol progestin receptor (CPR) levels are expressed as femtomoles of 3H-R5020 per mg of protein; results are means f SEM. Each sample consisted of MBH-POA regions or pituitaries from two animals.
Results and Discussion
It has been shown previously that the administration of P (2.5 mg in propylene glycol) to animals which have received Silastic capsules containing 10% estradiol produces an increase in the lordosis quotient (LQ) and lordosis quality (LS) scores within 3 to 4 hr (Parsons et al., 1981a ). This increase is transient and is not observed 22 hr later (Parsons et al., 1981a) . As seen in Table I , the administration of progesterone (0.5 mg) at 24 hr produces a lesser facilitation of LQ and LS scores in animals which have received P (2.5 mg) previously. This observation supports previous findings, referred to as "sequential inhibition" of mating behavior by P (Zucker, 1966; Powers and Moreines, 1976; Blaustein and Wade, 1977; Blaustein and Feder, 1979; Schwartz et al., 1979; Parsons et al., 1981a) .
The antibiotic, anisomycin, has been shown previously to inhibit substantially protein synthesis in those areas of the brain known to mediate feminine sexual behavior, the MBH and POA. When given as a single subcutaneous injection (100 mg/kg), anisomycin inhibits protein syn- Figure 1. The experimental design for our investigations is summarized in this diagram. Females ovariectomized for 5 to 8 days received a 5-mm Silastic capsule containing 10% e&radio1 (Ez) at -72 hr. All females received subcutaneous injections of progesterone (P, 2.5 mg) or of propylene glycol (PG) at 0 hr. Females also received subcutaneous injections of the protein synthesis inhibitor, anisomycin (20 mg/kg), or of saline. Anisomycin (ANI) or saline was administered 15 min prior to, and again 3 hr after, P/PG treatment. Twenty-four hours after P/PG treatment, some animals were sacrificed for cytosol progestin receptor measurements. The remaining animals received subcutaneous injections of P (0.5 mg) and were given mating tests 4 hr later (28 hr). PG + saline 90.0 f 3.2" (n = 5) 1.72 + 0.11" 16.0 + 0.4h (n = 3) 39.9 k 1.6 PG + anisomycin 80.0 + 11.8" (n = 6) 1.55 + 0.32" 10.1 rt 0.9',' (n = 3) 34.5 + 1.7 P + saline 65.0 f 6.5" (n = 12) 1.00 + 0.12" 11.4 f 0.8' (n = 5) 28.3 z!z 1.9 P + anisomycin 92.2 -C 4X." (n = 9) 1.88 f 0.16",' 9.1 + 0.9'," (n = 5) 26. thesis by 92% and 56% in the hypothalamus 30 min and 4 hr, respectively, after administration (Rainbow et al., 1980) . In order to test whether protein synthesis is involved in the inhibitory actions of P which result in "sequential inhibition," we administered anisomycin immediately prior to and again 3 hr after P or PG treatment. We found that the administration of anisomycin (100 mg/kg) immediately prior to and again 3 hr after P (2.5 mg) treatment abolished the "sequential inhibition" of mating behavior at 28 hr (Table I ). In animals which received vehicle (PG) injections, the same schedule of anisomycin had no positive or negative effect on LQ or LS scores at 28 hr (Table I) . Thus, the abolition of "sequential inhibition" by anisomycin is related to a blockade of progesterone action.
We used anisomycin to demonstrate the time course of the changes in protein synthesis which are essential for the "sequential inhibition" of mating behavior. If a single anisomycin (100 mg/kg) injection is given 15 min prior to P (2.5 mg) administration, "sequential inhibition" of mating behavior is still observed 24 hr later, as measured by the LQ and LS scores (Table II) . However, if single anisomycin (100 mg/kg) injections are given 3 or 9 hr after P (2.5 mg) administration, "sequential inhibition" of mating behavior is not observed at 24 hr (Table  II) . At 13 or 17 hr after P (2.5 mg) administration, single anisomycin injections are no longer effective in abolishing "sequential inhibition" by P (Table II) . Since a single anisomycin (100 mg/kg) injection produces a period of protein synthesis inhibition (50% or greater) of about 4 hr in the hypothalamus, these data indicate that a large portion of the protein synthesis which is essential for the inhibition of mating behavior occurs between 3 and 13 hr after the administration of P (2.5 mg).
A decrease in hypothalamic cytosol progestin receptors 24 hr after administration of large doses of P (e.g., 2.5 mg) has been correlated previously with a decreased facilitation of mating behavior at this time, both in the guinea pig (Blaustein and Feder, 1979) and rat (Moguilewsky and Raynaud, 1979; Schwartz et al., 1979; Parsons et al., 1981a) . This decrease in cytosol progestin receptor levels 24 hr after P administration appears to be either a down-regulation of cytosol binding sites by P or a delay in the recycling of the receptor from the nucleus to the cytoplasm (Parsons et al., 1981a) . If there is a causal relationship between decreased cytosol progestin receptor levels and the "sequential inhibition" of mating behavior by P, then cytosol progestin levels in animals which have received anisomycin plus P (and which show no behavioral deficit at 24 hr) should not be depleted relative to animals which have received saline plus P (and which show decreased LQ and LS scores at 24 hr). We found to the contrary that anisomycin plus P treatment decreased cytosol progestin receptors in the MBH-POA and pituitary more than saline plus P treatment (Table I) . Although 2.5 mg of P reduced cytosol progestin receptor levels in MBH-POA and pituitary 24 hr after administration whether anisomycin or saline were concurrently administered, the behavioral and biochemical data obtained with anisomycin plus P treatment indicate that the reduction in cytosol progestin receptor levels was unrelated to the sequential inhibition of sexual receptivity (Table I) . We conclude that the "sequential inhibition" of mating behavior by P appears to involve an essential step that is not related causally to decreased CPR levels in the hypothalamus or pituitary. It appears that the progesterone-dependent step includes protein synthesis, although strictly speaking, we cannot dismiss possible drug side effects of anisomycin, or other chemical processes, as playing some role (Rainbow et al., 1980) . Vol. 1, No. 5, May 1981 Antibiotics have been employed successfully as reversible inhibitors of steroid-induced changes in sexual receptivity and proceptivity (Wallen et al., 1972; Quadagno and Ho, 1975; Rainbow et al., 1980; Parsons et al., 1981b et al., 1979) . Progesterone also has been shown to be translocated by cytosol receptors to the cell nucleus in brain cells (Blaustein and Feder, 1980) . Furthermore, in this paper, we have presented evidence which is consistent with, but not proof of, a model in which the inhibition of mating behavior by progesterone is related to P-induced changes in gene expression and protein synthesis. A large portion of the presumed protein synthesis which is essential for the inhibition of mating behavior occurs between 3 and 13 hr after P (2.5 mg) administration.
Our results indicate that this protein synthesis appears to be dissociated from the reduction in brain and pituitary progestin receptors which also occurs following P (2.5 mg) administration. At present, we have no knowledge of the identity of the proteins associated with the inhibition of sexual receptivity by progesterone or of those proteins associated with the facilitation of lordosis by P (Rainbow et al., 1980) . The identification of these proteins, and the manner in which they are intraneuronally integrated to determine whether lordosis occurs, remains a fertile area for future investigation.
